Literature DB >> 30484928

Impaired generalization of reward but not loss in obsessive-compulsive disorder.

Nina Rouhani1,2, George Elliott Wimmer3, Franklin R Schneier4, Abby J Fyer4, Daphna Shohamy5,6, Helen Blair Simpson4.   

Abstract

BACKGROUND: Generalizing from past experiences can be adaptive by allowing those experiences to guide behavior in new situations. Generalizing too much, however, can be maladaptive. For example, individuals with pathological anxiety are believed to overgeneralize emotional responses from past threats, broadening their scope of fears. Whether individuals with pathological anxiety overgeneralize in other situations remains unclear.
METHODS: The present study (N = 57) used a monetary sensory preconditioning paradigm with rewards and losses to address this question in individuals with obsessive-compulsive disorder (OCD) and social anxiety disorder (SAD), comparing them to healthy comparison subjects (HC). In all groups, we tested direct learning of associations between cues and reward vs. loss outcomes, as well as generalization of learning to novel choice options.
RESULTS: We found no differences between the three groups in the direct learning of stimuli with their outcomes: all subjects demonstrated intact stimulus-response learning by choosing rewarding options and avoiding negative ones. However, OCD subjects were less likely to generalize from rewards than either the SAD or HC groups, and this impairment was not found for losses. Additionally, greater deficits in reward generalization were correlated with severity of threat estimation, as measured by a subscale of the Obsessive Beliefs Questionnaire, both within OCD and across all groups.
CONCLUSIONS: These findings suggest that a compromised ability to generalize from rewarding events may impede adaptive behavior in OCD and in those susceptible to high estimation of threat.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cognition; decision-making; reinforcement learning; reward generalization; sensory preconditioning

Mesh:

Year:  2018        PMID: 30484928     DOI: 10.1002/da.22857

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  6 in total

1.  Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study.

Authors:  Reilly R Kayser; Margaret Haney; Marissa Raskin; Caroline Arout; Helen Blair Simpson
Journal:  Depress Anxiety       Date:  2020-05-07       Impact factor: 6.505

Review 2.  Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway.

Authors:  Alexandre Vallée; Yves Lecarpentier; Jean-Noël Vallée
Journal:  Mol Psychiatry       Date:  2021-04-09       Impact factor: 15.992

Review 3.  Toward a neurocircuit-based taxonomy to guide treatment of obsessive-compulsive disorder.

Authors:  Elizabeth Shephard; Emily R Stern; Odile A van den Heuvel; Daniel L C Costa; Marcelo C Batistuzzo; Priscilla B G Godoy; Antonio C Lopes; Andre R Brunoni; Marcelo Q Hoexter; Roseli G Shavitt; Y C Janardhan Reddy; Christine Lochner; Dan J Stein; H Blair Simpson; Euripedes C Miguel
Journal:  Mol Psychiatry       Date:  2021-01-07       Impact factor: 15.992

4.  Neural Processing Dysfunctions During Fear Learning but Not Reward-Related Processing Characterize Depressed Individuals With High Levels of Repetitive Negative Thinking.

Authors:  Heekyeong Park; Namik Kirlic; Rayus Kuplicki; Martin Paulus; Salvador Guinjoan
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2022-01-20

Review 5.  WNT/β-catenin pathway and circadian rhythms in obsessive-compulsive disorder.

Authors:  Alexandre Vallee; Yves Lecarpentier; Jean-Noël Vallée
Journal:  Neural Regen Res       Date:  2022-10       Impact factor: 6.058

6.  Infralimbic medial prefrontal cortex signalling to calbindin 1 positive neurons in posterior basolateral amygdala suppresses anxiety- and depression-like behaviours.

Authors:  Huiling Yu; Liping Chen; Huiyang Lei; Guilin Pi; Rui Xiong; Tao Jiang; Dongqin Wu; Fei Sun; Yang Gao; Yuanhao Li; Wenju Peng; Bingyu Huang; Guoda Song; Xin Wang; Jingru Lv; Zetao Jin; Dan Ke; Ying Yang; Jian-Zhi Wang
Journal:  Nat Commun       Date:  2022-09-17       Impact factor: 17.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.